WallStSmart

Arthur J Gallagher & Co (AJG)vsEthos Technologies Inc. Class A Common Stock (LIFE)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Arthur J Gallagher & Co generates 3256% more annual revenue ($13.01B vs $387.61M). LIFE leads profitability with a 18.4% profit margin vs 11.5%. LIFE trades at a lower P/E of 8.6x. LIFE earns a higher WallStSmart Score of 66/100 (B-).

AJG

Buy

60

out of 100

Grade: C

Growth: 6.7Profit: 5.0Value: 7.3Quality: 4.3
Piotroski: 4/9Altman Z: 0.76

LIFE

Strong Buy

66

out of 100

Grade: B-

Growth: 8.0Profit: 8.0Value: 8.3Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

AJGSignificantly Overvalued (-426.0%)

Margin of Safety

-426.0%

Fair Value

$39.03

Current Price

$213.56

$174.53 premium

UndervaluedFair: $39.03Overvalued
LIFEUndervalued (+80.7%)

Margin of Safety

+80.7%

Fair Value

$53.35

Current Price

$10.09

$43.26 discount

UndervaluedFair: $53.35Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

AJG4 strengths · Avg: 8.8/10
Revenue GrowthGrowth
36.7%10/10

Revenue surging 36.7% year-over-year

Market CapQuality
$54.91B9/10

Large-cap with strong market position

PEG RatioValuation
0.938/10

Growing faster than its price suggests

Price/BookValuation
2.4x8/10

Reasonable price relative to book value

LIFE4 strengths · Avg: 9.3/10
P/E RatioValuation
8.6x10/10

Attractively priced relative to earnings

Revenue GrowthGrowth
65.5%10/10

Revenue surging 65.5% year-over-year

Return on EquityProfitability
21.0%9/10

Every $100 of equity generates 21 in profit

Operating MarginProfitability
22.2%8/10

Strong operational efficiency at 22.2%

Areas to Watch

AJG4 concerns · Avg: 2.8/10
P/E RatioValuation
37.2x4/10

Premium valuation, high expectations priced in

Return on EquityProfitability
6.9%3/10

ROE of 6.9% — below average capital efficiency

EPS GrowthGrowth
-48.3%2/10

Earnings declined 48.3%

Altman Z-ScoreHealth
0.762/10

Distress zone — elevated risk

LIFE2 concerns · Avg: 3.5/10
EPS GrowthGrowth
1.6%4/10

1.6% earnings growth

Market CapQuality
$618.69M3/10

Smaller company, higher risk/reward

Comparative Analysis Report

WallStSmart Research

Bull Case : AJG

The strongest argument for AJG centers on Revenue Growth, Market Cap, PEG Ratio. Revenue growth of 36.7% demonstrates continued momentum. PEG of 0.93 suggests the stock is reasonably priced for its growth.

Bull Case : LIFE

The strongest argument for LIFE centers on P/E Ratio, Revenue Growth, Return on Equity. Profitability is solid with margins at 18.4% and operating margin at 22.2%. Revenue growth of 65.5% demonstrates continued momentum.

Bear Case : AJG

The primary concerns for AJG are P/E Ratio, Return on Equity, EPS Growth.

Bear Case : LIFE

The primary concerns for LIFE are EPS Growth, Market Cap.

Key Dynamics to Monitor

LIFE is growing revenue faster at 65.5% — sustainability is the question.

AJG generates stronger free cash flow (713M), providing more financial flexibility.

Monitor INSURANCE BROKERS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

LIFE scores higher overall (66/100 vs 60/100), backed by strong 18.4% margins and 65.5% revenue growth. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Arthur J Gallagher & Co

FINANCIAL SERVICES · INSURANCE BROKERS · USA

Arthur J. Gallagher & Co. (AJG) is an American global insurance brokerage and risk management services firm headquartered in Rolling Meadows, Illinois.

Ethos Technologies Inc. Class A Common Stock

FINANCIAL SERVICES · INSURANCE BROKERS · USA

aTyr Pharma, Inc., a clinical-stage biotherapeutics company, is dedicated to the discovery and development of drugs based on new immune pathways in the United States. The company is headquartered in San Diego, California.

Want to dig deeper into these stocks?